United Immunity
Tokyo
About United Immunity
United Immunity is a research, development, manufacture and sale of pharmaceuticals, mainly for cancer immunotherapy.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 11 – 50
- Estimated revenue: $10K – $50K
- Total funding: $6.6M
- Funding stage: Early Stage Venture
- Last round: Debt Financing (Mar 2024)
- Website: unitedimmunity.co.jpeng
- Phone: +81-059-231-5484
Industries & Categories
Health Care, Nursing and Residential Care, Nutrition
Social Profiles
Canonical: https://fsome.com/organization/united-immunity-43561 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.